Papadaki, C., Sfakianaki, M., Lagoudaki, E., Giagkas, G., Ioannidis, G., Trypaki, M., . . . Souglakos, J. (2014). PKM2 as a biomarker for chemosensitivity to front-line platinum-based chemotherapy in patients with metastatic non-small-cell lung cancer. Br J Cancer.
Citação norma ChicagoPapadaki, C., et al. "PKM2 As a Biomarker for Chemosensitivity to Front-line Platinum-based Chemotherapy in Patients With Metastatic Non-small-cell Lung Cancer." Br J Cancer 2014.
Citação norma MLAPapadaki, C., et al. "PKM2 As a Biomarker for Chemosensitivity to Front-line Platinum-based Chemotherapy in Patients With Metastatic Non-small-cell Lung Cancer." Br J Cancer 2014.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.